Prophylactic urokinase in the management of long-term venous access devices in children: A Children's Oncology Group study

Journal of Clinical Oncology

Volumn 22, Issue 13, 2004, Pages 2718-2723

  Dillon, Peter W ^a   Jones, Gary R ^a   Bagnall Reeb, Holly A ^a   Buckley, Jonathan D ^a   Wiener, Eugene S ^a   Haase, Gerald M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; UROKINASE; ANTINEOPLASTIC AGENT; PLASMINOGEN ACTIVATOR;

ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; OCCLUSION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT OUTCOME; VASCULAR ACCESS; ADOLESCENT; ADULT; COMPARATIVE STUDY; FEMALE; INFANT; INFECTION CONTROL; MALE; MULTICENTER STUDY; NEOPLASM; NEWBORN; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; MALE; NEOPLASMS; PLASMINOGEN ACTIVATORS; THROMBOSIS; URINARY PLASMINOGEN ACTIVATOR;

EID: 4344590282     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.07.019     Document Type: Article

References (21)

1. Wiener ES, McGuire P, Stolar CJH, et al: The CCSG prospective study of venous access devices: An analysis of insertions and causes for removal. J Pediatr Surg 27:155-164, 1992
2. Fan CM: Tunneled catheters. Semin Intervent Radiol 15:273-286, 1998
3. Darouiche RO: Device-associated infections: A macroproblem that starts with microadherence. Clin Infect Dis 33:1567-1572, 2001
4. Musher D, Goldsmith E, Dunbar S, et al: Association of hypercoagulable states and increased platelet adhesion and aggregation with bacterial colonization of intravenous catheters. J Infect Dis 186:769-773, 2002
5. Lawson M, Bottino JC, Hurtubise MR, et al: The use of urokinase to restore the patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr 9:29-30, 1982
6. Wachs T: Urokinase administration in pediatric patients with occluded central venous catheters. J Intraven Nurs 13:100-102, 1990
7. Lawson M: Partial occlusion of indwelling central venous catheters. J Intraven Nurs 14:157-159, 1991
8. Bagnall-Reeb HA, Saltzman DA, Smith CM, et al: Prophylactic scheduled urokinase for the prevention of right atrial catheter infection. Oncol Nurs Forum 20:315, 1993
9. Ray CE, Shenoy S, McCarthy PL, et al: Weekly prophylactic urokinase installation in tunneled central venous access devices. J Vasc Interv Radiol 10:1330-1334, 1999
10. Kalmanti M, Germanakis J, Stiakaki E, et al: Prophylaxis with urokinase in pediatric oncology patients with central venous catheters. Pediatr Hematol Oncol 19:173-179, 2002
11. O'Farrell L, Griffith JW, Lang CM: Histologic development of the sheath that forms around long-term implanted central venous catheters. JPEN J Parenter Enteral Nutr 20:156-158, 1996
12. Mehall JR, Saltzman DA, Jackson RJ, et al: Fibrin sheath enhances central venous catheter infection. Crit Care Med 30:908-912, 2002
13. Guenier C, Ferreira J, Pector JC: Prolonged venous access in cancer patients. Eur J Surg Oncol 15:553-555, 1989
14. Mirro J Jr, Rao BN, Sokes DC, et al: A prospective study of hickman/broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 7:214-222, 1989
15. Severien C, Nelson JD: Frequency of infections associated with implantable systems vs cuffed, tunneled silastic venous catheters in patients with acute leukemia. Am J Dis Child 145:1433-1438, 1991
16. Groeger JS, Lucas AB, Thaler HT, et al: Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168-1174, 1993
17. Fraschini G, Becker M, Bruso P, et al: Comparative trial of urokinase versus heparin as prophylaxis for central venous ports. Proc Am Soc Clin Oncol 10:337, 1991 (abstr 1193)
18. Aquino VM, Sandler EX, Mustafa MM, et al: A prospective double blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters. J Pediatr Hematol Oncol 24:710-713, 2002
19. Solomon B, Moore J, Arthur C, et al: Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomized comparison of urokinase and heparin. Eur J Cancer 37:2379-2384, 2001
20. Bern MM, Lokich JJ, Wallach SR, et al: Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423-428, 1990
21. Boraks P, Seale J, Price J, et al: Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 101:483-486, 1998